Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 553, pseudogene (RN7SL553P) is a **pseudogene**, meaning it is a genomic DNA segment that closely resembles a functional gene but is generally considered nonfunctional and does not encode a functional product[1][6][7][8]. Specifically, RN7SL553P is classified as a 7SL RNA-derived pseudogene; the authentic 7SL RNA is an essential component of the **signal recognition particle (SRP)** ribonucleoprotein complex, which mediates the targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells[5]. However, pseudogenes like RN7SL553P do not produce functional RNA or protein and are not considered druggable or therapeutic targets; they lack roles as receptors, enzymes, transporters, or related classes relevant for drug targeting[1][6][7]. Their biological functions in physiology or disease are generally absent, although emerging evidence suggests some pseudogenes could potentially have regulatory roles, such as acting as competing endogenous RNAs or miRNA sponges in other contexts[4]; no specific evidence associates RN7SL553P with such activity. RN7SL553P has no known disease association, interacting drugs, mechanism-of-action, biomarker utility, or notable safety concern. Since it lacks therapeutic target credentials and functional annotation, RN7SL553P is not considered a druggable target and the query asking for receptor or target details is **incorrect** in context[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 553, pseudogene (RN7SL553P).